WallStreetZenWallStreetZen

NASDAQ: RIGL
Rigel Pharmaceuticals Inc Stock Ownership - Who owns Rigel Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rigel Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dean L. SchornoCFO;EVP2026-09-02694$12.70
$8.81kBuy
Dean L. SchornoCFO;EVP2026-09-021,286$24.20
$31.12kBuy
Dean L. SchornoCFO;EVP2026-09-02620$18.70
$11.59kBuy
Dean L. SchornoCFO;EVP2026-09-022,000$24.20
$48.40kBuy
David A. SantosCCO;EVP2026-09-01874$47.50
$41.52kSell
Raul R. RodriguezCEO;Pres2026-09-012,424$47.50
$115.14kSell
Raymond J. FureyCCO;Sec;EVP2026-09-01877$47.50
$41.66kSell
Dean L. SchornoCFO;EVP2026-09-01928$47.50
$44.08kSell
Kamil AlijacksonDirector2026-06-222,500$35.00
$87.50kSell
Lisa RojkjaerEVP Chief Medical Officer2026-06-01850$29.86
$25.38kSell

1 of 4

RIGL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RIGL insiders and whales buy or sell their stock.

RIGL Shareholders

What type of owners hold Rigel Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P89.19%16,660,120$813.18MInsider
James E. Flynn36.09%6,742,289$329.09MInsider
Raul R. Rodriguez1.46%273,362$13.34MInsider
Eldon C. Mayer Iii1.15%215,000$10.49MInsider
James M. Gower0.97%180,676$8.82MInsider
Donald G. Payan0.60%111,365$5.44MInsider
Brian L. Kotzin0.54%100,000$4.88MInsider
Dean L. Schorno0.44%82,962$4.05MInsider
Gary A. Lyons0.40%75,000$3.66MInsider
Wolfgang Dummer0.39%72,459$3.54MInsider

1 of 3

RIGL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RIGL0.07%99.93%Net SellingNet Selling
MLTX0.09%22.01%Net SellingNet Selling
KURA0.10%11.09%Net SellingNet Buying
ANRO0.08%16.24%Net BuyingNet Buying
SPTX0.07%74.84%Net Buying
View Top Biotech Stocks

Rigel Pharmaceuticals Stock Ownership FAQ

Who owns Rigel Pharmaceuticals?

Rigel Pharmaceuticals (NASDAQ: RIGL) is owned by 0.09% institutional shareholders, 133.47% Rigel Pharmaceuticals insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Rigel Pharmaceuticals shareholder, owning 16.66M shares representing 89.19% of the company. Bvf Partners L P's Rigel Pharmaceuticals shares are currently valued at $785.36M.

If you're new to stock investing, here's how to buy Rigel Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.